Sherif M. Elbasiouny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sherif M. Elbasiouny has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Mohamed H. Mousa
Department of Neuroscience, Cell Biology, and Physiology, Boonshoft School of Medicine, College of Science and Mathematics, Wright State University
9 shared publicationsTeresa L. Garrett
Department of Neuroscience, Cell Biology, and Physiology, Boonshoft School of Medicine, College of Science and Mathematics, Wright State University, Dayton, OH 45435, USA
4 shared publicationsIbrahim Abdul Halim
Department of Biomedical, Industrial, and Human Factors Engineering, College of Engineering and Computer Science, Wright State University
3 shared publications- Morgan M. Highlander
Department of Biomedical, Industrial, and Human Factors Engineering, College of Engineering and Computer Science, Wright State University, Dayton, OH 45435, USA
3 shared publications - Amr A. Mahrous
Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
2 shared publications John M. Allen
Department of Biomedical, Industrial and Human Factors Engineering, College of Engineering and Computer Science, Wright State University, Dayton, OH, United States
2 shared publications
Latest Publications
- Open Access
- 28 May 2026
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 433, 110815
Optimized multiplex immunofluorescent protocols for simultaneous in situ identification of α-motoneuron subtypes
- 28 May 2026
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 433, 110815
Open AccessOptimized multiplex immunofluorescent protocols for simultaneous in situ identification of α-motoneuron subtypes
- Open Access
- 4 February 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1687226
SK channel upregulation and sex-specific mechanisms drive spinal motoneuron reduced excitability with age
Introduction: Mechanisms underlying age-related weakness are not fully understood, with neuronal mechanisms recently gaining attention. Despite studies on excitatory and inhibitory inputs, conflicting findings on α -motoneuron intrinsic excitability and PIC changes highlight a major gap in explaining age-related strength decline. Methods: Using electrophysiological and immunohistochemical approaches, we present direct assessment of intrinsic excitability, cell size, and ion channel membrane expression in adult spinal α -motoneuron types of male and female mice across three age groups: young (3–4 months), middle aged (12–14 months), and old (24–30 months). To account for variability in aging and assess the association with motor function, these physiological and histological parameters were correlated with forelimb and hindlimb grip strength. Results: Our findings reveal a decline in intrinsic excitability of spinal α -motoneurons with aging in both male and female mice, with a more pronounced e!ect in females. Specifically, female motoneurons show increase in rheobase and reduction in firing gain, whereas in males, only firing gain is reduced. Moreover, age-related strength is correlated with α - motoneuron excitability; the lower the α -motoneuron excitability, the weaker the aged mouse. Notably, fast-type α -motoneurons are the most affected by aging-related excitability decline. Further mechanistic analysis indicates sex-specific differences in motoneuron aging: female motoneurons exhibit increased cell capacitance, hyperpolarized resting membrane potential (RMP), and increased expression of SK channels, while male motoneuron show increased expression of SK channels without cell capacitance or RMP alterations. SK increased expression was specific to FF and FI types in male and female mice. Discussion: These findings reveal sex-specific aging mechanisms in motoneurons, explain women’s higher frailty risk, and identify novel drug targets to counteract age-related muscle weakness and neuromuscular decline in older adults.
- 4 February 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1687226
Open AccessSK channel upregulation and sex-specific mechanisms drive spinal motoneuron reduced excitability with age
Introduction: Mechanisms underlying age-related weakness are not fully understood, with neuronal mechanisms recently gaining attention. Despite studies on excitatory and inhibitory inputs, conflicting findings on α -motoneuron intrinsic excitability and PIC changes highlight a major gap in explaining age-related strength decline. Methods: Using electrophysiological and immunohistochemical approaches, we present direct assessment of intrinsic excitability, cell size, and ion channel membrane expression in adult spinal α -motoneuron types of male and female mice across three age groups: young (3–4 months), middle aged (12–14 months), and old (24–30 months). To account for variability in aging and assess the association with motor function, these physiological and histological parameters were correlated with forelimb and hindlimb grip strength. Results: Our findings reveal a decline in intrinsic excitability of spinal α -motoneurons with aging in both male and female mice, with a more pronounced e!ect in females. Specifically, female motoneurons show increase in rheobase and reduction in firing gain, whereas in males, only firing gain is reduced. Moreover, age-related strength is correlated with α - motoneuron excitability; the lower the α -motoneuron excitability, the weaker the aged mouse. Notably, fast-type α -motoneurons are the most affected by aging-related excitability decline. Further mechanistic analysis indicates sex-specific differences in motoneuron aging: female motoneurons exhibit increased cell capacitance, hyperpolarized resting membrane potential (RMP), and increased expression of SK channels, while male motoneuron show increased expression of SK channels without cell capacitance or RMP alterations. SK increased expression was specific to FF and FI types in male and female mice. Discussion: These findings reveal sex-specific aging mechanisms in motoneurons, explain women’s higher frailty risk, and identify novel drug targets to counteract age-related muscle weakness and neuromuscular decline in older adults.
- Open Access
- 27 October 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1706131
Methodological and analytical limitations undermine reported outcomes of spinal DC stimulation in ALS
Amyotrophic lateral sclerosis (ALS) is a fatal motoneuron disease that causes progressive loss of motor function and paralysis. While the exact causes of motoneuron degeneration remain unclear, abnormal electrical excitability of motoneurons 1 and altered cortical excitability 2 are consistent features 2 . Treatments that normalize this excitability have shown promise in animal studies and influence current approved drugs 3,4 . However, existing pharmacological therapies provide only limited improvements in motor function and survival [5][6][7][8] , highlighting the need for more effective treatment approaches.Electroceuticals, which use targeted electrical stimulation rather than systemic drugs, offer a promising approach to regulate neuronal excitability. Therefore, a variety of electrical stimulation approaches have been studied in ALS including cortical 2,9 and spinal [10][11][12][13][14][15] stimulations. So far, results are variable and the clinical impacts on disease progression have been limited 16 .Standing out from these prior studies, a recent study by Ahmed et al. examined the effects of anodal spinal DCS on the SOD1-G93A mouse model of ALS using unique electrode placements called "Multi-path DCS" 17 . The treatment effects reported were profound, including prolonged motor function and an astounding improvement in animal survival of 74% 17 . Such significant results warrant a deeper look into the study, which unfortunately uncovers several flaws that undermine the impact of results, as explained below. All figures referenced in the following text pertain to the Ahmed et al. study 17 .2.1 Garnering False Hope: 74% Survival Improvement is Actually 5%In preclinical models, the standard measure of survival is the interval from birth to when the animal reaches the humane endpoint (i.e., survival-from-birth) 10,[18][19][20][21][22] , providing a direct measure of lifespan. In contrast, the study by Ahmed et al. quantifies survival as the duration between symptom onset and the humane endpoint (called survival-from-symptom onset), which more accurately reflects the progression of clinical symptoms rather than overall survival. While this measure may offer insights into disease trajectory, it does not constitute a valid proxy for lifespan extension, especially since symptom onset detection can be subjective and imprecise. Therefore, the reported 74% increase in survival-from-symptom-onset does not reflect a substantive improvement in total survival. The use of the term "survival" in this context is therefore misleading, as it inflates the perceived therapeutic benefit. Importantly, when survival-from-birth was directly assessed (Fig. 2D), the observed increase in lifespan among stimulated animals was approximately 5%, indicating a considerably more modest effect than initially suggested.Although both parametric and non-parametric statistical analyses of survival data are presented, neither approach is supported by appropriate validation of underlying assumptions. Specifically, independent t-tests were applied to both survival-from-birth and survival-from-symptom onset datasets (Figs. 2B and2D), yet no assessment of normality was reported. If the data are not normally distributed, the application of the t-test is inappropriate and renders the resulting p-values unreliable. Conversely, for the non-parametric analyses (Figs. 2A and2C), the Breslow test was employed rather than the more commonly accepted Log-Rank test. The Breslow test assigns greater weight to early events, whereas the Log-Rank test distributes weight uniformly across time points 23 . The authors provide no rationale for prioritizing early deaths over later ones, raising concerns about the suitability of the Breslow test. This issue is particularly relevant given the data in Fig. 2D, which indicate that two animals in the nonstimulated group died markedly earlier than the rest, and also earlier than expected based on published survival data for this model 24 . It is plausible that the reported 74% survival improvement is disproportionately influenced by these outliers. Additionally, given their early death, it is unclear whether these animals survived long enough past their symptom onset to receive a single sham stimulation or died before receiving any sham stimulation. Collectively, the absence of normality testing and the questionable use of weighting in non-parametric tests undermine the statistical validity of the survival-from-birth and survival-from-symptom onset findings, reducing confidence in the reported treatment effects.Another significant concern regarding the "survival-from-symptom onset" metric reported by the authors is the bias introduced by delayed and unvalidated detection of symptom onset. Accurate identification of symptom onset is critical in this context, as the 74% increase in survival-from-onset is calculated from this event. However, the ages at which symptom onset was detected in both groups were not reported in the study, making it impossible to assess the validity or consistency of this measurement.Notably, while the survival-from-birth for the non-stimulated group (129.7±2.3 days) aligns closely with published data for the SOD1-G93A high copy mouse model (130.2±11.2 days) 24 , the reported survival-from-onset (12.4±1.4 days) is markedly shorter than the 61-62 days commonly reported in literature 19 . This substantial discrepancy suggests that symptom onset in the current study was detected significantly later than in prior reports. This result is not unexpected given that the scoring method used to determine symptom onset was originally developed for assessing spasticity following spinal cord injury 25 , and has not been validated against established ALS onset markers such as tremor onset 19 , rotarod performance 20 , neuroscrore 21 , treadmill endurance 20 , or hanging-wire test 20 . While the authors attempt to justify their approach by providing correlation data...
- 27 October 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1706131
Open AccessMethodological and analytical limitations undermine reported outcomes of spinal DC stimulation in ALS
Amyotrophic lateral sclerosis (ALS) is a fatal motoneuron disease that causes progressive loss of motor function and paralysis. While the exact causes of motoneuron degeneration remain unclear, abnormal electrical excitability of motoneurons 1 and altered cortical excitability 2 are consistent features 2 . Treatments that normalize this excitability have shown promise in animal studies and influence current approved drugs 3,4 . However, existing pharmacological therapies provide only limited improvements in motor function and survival [5][6][7][8] , highlighting the need for more effective treatment approaches.Electroceuticals, which use targeted electrical stimulation rather than systemic drugs, offer a promising approach to regulate neuronal excitability. Therefore, a variety of electrical stimulation approaches have been studied in ALS including cortical 2,9 and spinal [10][11][12][13][14][15] stimulations. So far, results are variable and the clinical impacts on disease progression have been limited 16 .Standing out from these prior studies, a recent study by Ahmed et al. examined the effects of anodal spinal DCS on the SOD1-G93A mouse model of ALS using unique electrode placements called "Multi-path DCS" 17 . The treatment effects reported were profound, including prolonged motor function and an astounding improvement in animal survival of 74% 17 . Such significant results warrant a deeper look into the study, which unfortunately uncovers several flaws that undermine the impact of results, as explained below. All figures referenced in the following text pertain to the Ahmed et al. study 17 .2.1 Garnering False Hope: 74% Survival Improvement is Actually 5%In preclinical models, the standard measure of survival is the interval from birth to when the animal reaches the humane endpoint (i.e., survival-from-birth) 10,[18][19][20][21][22] , providing a direct measure of lifespan. In contrast, the study by Ahmed et al. quantifies survival as the duration between symptom onset and the humane endpoint (called survival-from-symptom onset), which more accurately reflects the progression of clinical symptoms rather than overall survival. While this measure may offer insights into disease trajectory, it does not constitute a valid proxy for lifespan extension, especially since symptom onset detection can be subjective and imprecise. Therefore, the reported 74% increase in survival-from-symptom-onset does not reflect a substantive improvement in total survival. The use of the term "survival" in this context is therefore misleading, as it inflates the perceived therapeutic benefit. Importantly, when survival-from-birth was directly assessed (Fig. 2D), the observed increase in lifespan among stimulated animals was approximately 5%, indicating a considerably more modest effect than initially suggested.Although both parametric and non-parametric statistical analyses of survival data are presented, neither approach is supported by appropriate validation of underlying assumptions. Specifically, independent t-tests were applied to both survival-from-birth and survival-from-symptom onset datasets (Figs. 2B and2D), yet no assessment of normality was reported. If the data are not normally distributed, the application of the t-test is inappropriate and renders the resulting p-values unreliable. Conversely, for the non-parametric analyses (Figs. 2A and2C), the Breslow test was employed rather than the more commonly accepted Log-Rank test. The Breslow test assigns greater weight to early events, whereas the Log-Rank test distributes weight uniformly across time points 23 . The authors provide no rationale for prioritizing early deaths over later ones, raising concerns about the suitability of the Breslow test. This issue is particularly relevant given the data in Fig. 2D, which indicate that two animals in the nonstimulated group died markedly earlier than the rest, and also earlier than expected based on published survival data for this model 24 . It is plausible that the reported 74% survival improvement is disproportionately influenced by these outliers. Additionally, given their early death, it is unclear whether these animals survived long enough past their symptom onset to receive a single sham stimulation or died before receiving any sham stimulation. Collectively, the absence of normality testing and the questionable use of weighting in non-parametric tests undermine the statistical validity of the survival-from-birth and survival-from-symptom onset findings, reducing confidence in the reported treatment effects.Another significant concern regarding the "survival-from-symptom onset" metric reported by the authors is the bias introduced by delayed and unvalidated detection of symptom onset. Accurate identification of symptom onset is critical in this context, as the 74% increase in survival-from-onset is calculated from this event. However, the ages at which symptom onset was detected in both groups were not reported in the study, making it impossible to assess the validity or consistency of this measurement.Notably, while the survival-from-birth for the non-stimulated group (129.7±2.3 days) aligns closely with published data for the SOD1-G93A high copy mouse model (130.2±11.2 days) 24 , the reported survival-from-onset (12.4±1.4 days) is markedly shorter than the 61-62 days commonly reported in literature 19 . This substantial discrepancy suggests that symptom onset in the current study was detected significantly later than in prior reports. This result is not unexpected given that the scoring method used to determine symptom onset was originally developed for assessing spasticity following spinal cord injury 25 , and has not been validated against established ALS onset markers such as tremor onset 19 , rotarod performance 20 , neuroscrore 21 , treadmill endurance 20 , or hanging-wire test 20 . While the authors attempt to justify their approach by providing correlation data...
- Open Access
Circular continuum of alpha motoneuron types
Alpha-motoneurons (α-MNs) are traditionally classified into slow (S), fast fatigue-resistant (FR), and fast-fatigable (FF), which exist along a continuum of properties between slow and fast, enabling the generation of graded force and seamless movement. Using combinations of markers, we developed novel immunohistochemistry protocols that enabled co-labeling of six major and transitional α-MN types throughout the mouse lumbar spinal cord with unprecedented detail. Intriguingly, our protocols labeled for the first time: α-MNs of the fast fatigue intermediate (FI) type; a previously undescribed transitional α-MN subtype (FR/FI); and a novel subtype of α-MNs exhibiting hybrid characteristics of both S and FF types – termed S/FF – which resist ALS degeneration. Electrophysiological recordings confirmed FR/FI and S/FF subtypes, both exhibiting mixed traits. The discovery of S/FF subtype reveals that α-MNs exist along a circular continuum between slow and fast types, challenging the traditional linear model and reshaping our understanding of their role in motor control. New & Noteworthy: This study introduces a novel immunohistochemistry protocol to co-label six distinct types of adult spinal cord motor neurons. This technical innovation led to a conceptual paradigm shift, revealing a circular continuum of motor neuron subtypes rather than a linear one. This new framework provides unprecedented precision for studying their varying susceptibility to degeneration in diseases like ALS, with broad implications for understanding motor control in health and disease.
Open AccessCircular continuum of alpha motoneuron types
Alpha-motoneurons (α-MNs) are traditionally classified into slow (S), fast fatigue-resistant (FR), and fast-fatigable (FF), which exist along a continuum of properties between slow and fast, enabling the generation of graded force and seamless movement. Using combinations of markers, we developed novel immunohistochemistry protocols that enabled co-labeling of six major and transitional α-MN types throughout the mouse lumbar spinal cord with unprecedented detail. Intriguingly, our protocols labeled for the first time: α-MNs of the fast fatigue intermediate (FI) type; a previously undescribed transitional α-MN subtype (FR/FI); and a novel subtype of α-MNs exhibiting hybrid characteristics of both S and FF types – termed S/FF – which resist ALS degeneration. Electrophysiological recordings confirmed FR/FI and S/FF subtypes, both exhibiting mixed traits. The discovery of S/FF subtype reveals that α-MNs exist along a circular continuum between slow and fast types, challenging the traditional linear model and reshaping our understanding of their role in motor control. New & Noteworthy: This study introduces a novel immunohistochemistry protocol to co-label six distinct types of adult spinal cord motor neurons. This technical innovation led to a conceptual paradigm shift, revealing a circular continuum of motor neuron subtypes rather than a linear one. This new framework provides unprecedented precision for studying their varying susceptibility to degeneration in diseases like ALS, with broad implications for understanding motor control in health and disease.
- 14 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Vol. 2025, 1-7
A Multi-Scale, High-Fidelity Computational Model of the Mouse Triceps Surae Motor Pool
This study introduces a novel, multi-scale, high- fidelity, computational model of the motoneuron pool innervating the mouse triceps surae muscle group. Designed to represent synaptic, anatomical, cellular, extracellular, and system-level dynamics, the model captures the unique electrical properties of mouse motoneurons. The model was rigorously validated against experimental measurements—including eleven key intracellular electrical properties and extracellular ventral root recordings—using extensive statistical analyses. These evaluations demonstrate that the model’s properties closely match in vivo observations, ensuring its accuracy and biological relevance. Consequently, this model serves as a versatile tool for investigating motoneuron behavior and motor unit dynamics in mice, offering valuable insights into neuromuscular function and potential applications in studying motoneurons in healthy and disease conditions.
- 14 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Vol. 2025, 1-7
A Multi-Scale, High-Fidelity Computational Model of the Mouse Triceps Surae Motor Pool
This study introduces a novel, multi-scale, high- fidelity, computational model of the motoneuron pool innervating the mouse triceps surae muscle group. Designed to represent synaptic, anatomical, cellular, extracellular, and system-level dynamics, the model captures the unique electrical properties of mouse motoneurons. The model was rigorously validated against experimental measurements—including eleven key intracellular electrical properties and extracellular ventral root recordings—using extensive statistical analyses. These evaluations demonstrate that the model’s properties closely match in vivo observations, ensuring its accuracy and biological relevance. Consequently, this model serves as a versatile tool for investigating motoneuron behavior and motor unit dynamics in mice, offering valuable insights into neuromuscular function and potential applications in studying motoneurons in healthy and disease conditions.
- 14 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Vol. 2025, 1-6
Sex and Age-Related Changes in Lean Mass of C57BL/6 Mice: A New Method for Assessing Body Composition
More than 40% of adults aged 65 and older have one or more physical disabilities that hinder their ability to perform essential daily tasks, significantly impacting their independence and quality of life. This study examines age-related changes in body composition in C57BL/6 mice to explore the relationship between lean mass, total mass, and age-related weakness. Using the EchoMRI-500 body composition analyzer, we measured lean mass and correlated it with independently measured total mass across different age groups (young, middle aged, and old) and sexes (male and female). Our results show that both lean and total mass increase progressively with age in both sexes. However, the lean-to-total mass ratio declines with age, reflecting the reduction in lean mass observed in humans. Additionally, male mice were consistently more muscular than female mice in old age. Specifically, the lean-to-total mass ratios were 0.525 for male mice and 0.203 for female mice. These data provide a simple yet accurate approach for estimating lean mass from total mass, offering a valuable tool for studying age-related weakness.
- 14 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
- Vol. 2025, 1-6
Sex and Age-Related Changes in Lean Mass of C57BL/6 Mice: A New Method for Assessing Body Composition
More than 40% of adults aged 65 and older have one or more physical disabilities that hinder their ability to perform essential daily tasks, significantly impacting their independence and quality of life. This study examines age-related changes in body composition in C57BL/6 mice to explore the relationship between lean mass, total mass, and age-related weakness. Using the EchoMRI-500 body composition analyzer, we measured lean mass and correlated it with independently measured total mass across different age groups (young, middle aged, and old) and sexes (male and female). Our results show that both lean and total mass increase progressively with age in both sexes. However, the lean-to-total mass ratio declines with age, reflecting the reduction in lean mass observed in humans. Additionally, male mice were consistently more muscular than female mice in old age. Specifically, the lean-to-total mass ratios were 0.525 for male mice and 0.203 for female mice. These data provide a simple yet accurate approach for estimating lean mass from total mass, offering a valuable tool for studying age-related weakness.
- Open Access
- 14 July 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (7) , 761
Precision in 3D: A Fast and Accurate Algorithm for Reproducible Motoneuron Structure and Protein Expression Analysis
Structural analysis of motoneuron somas and their associated proteins via immunohistochemistry (IHC) remains tedious and subjective, requiring costly software or adapted 2D manual methods that lack reproducibility and analytical rigor. Yet, neurodegenerative disease and aging research demands precise structural comparisons to elucidate mechanisms driving neuronal degeneration. To address this need, we developed a novel algorithm that automates repetitive and subjective IHC analysis tasks, enabling thorough, objective, blinded, order-agnostic, and reproducible 3D batch analysis. With no manual tracing, the algorithm produces 3D Cartesian reconstructions of motoneuron somas from 60× IHC images of mouse lumbar spinal tissue. From these reconstructions, it measures 3D soma volume and efficiently quantitates net somatic protein expression and macro-cluster size. In this validation study, we applied the algorithm to assess soma size and C-bouton expression in various healthy control mice, comparing its measurements against manual measurements and across multiple algorithm users to confirm its accuracy and reproducibility. This novel, customizable tool enables efficient and high-fidelity 3D motoneuron analysis, replacing tedious, qualitative, cell-by-cell manual tuning with automatic threshold adaptation and quantified batch settings. For the first time, we attain reproducible results with quantifiable accuracy, exhaustive sampling, and a high degree of objectivity.
- 14 July 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (7) , 761
Open AccessPrecision in 3D: A Fast and Accurate Algorithm for Reproducible Motoneuron Structure and Protein Expression Analysis
Structural analysis of motoneuron somas and their associated proteins via immunohistochemistry (IHC) remains tedious and subjective, requiring costly software or adapted 2D manual methods that lack reproducibility and analytical rigor. Yet, neurodegenerative disease and aging research demands precise structural comparisons to elucidate mechanisms driving neuronal degeneration. To address this need, we developed a novel algorithm that automates repetitive and subjective IHC analysis tasks, enabling thorough, objective, blinded, order-agnostic, and reproducible 3D batch analysis. With no manual tracing, the algorithm produces 3D Cartesian reconstructions of motoneuron somas from 60× IHC images of mouse lumbar spinal tissue. From these reconstructions, it measures 3D soma volume and efficiently quantitates net somatic protein expression and macro-cluster size. In this validation study, we applied the algorithm to assess soma size and C-bouton expression in various healthy control mice, comparing its measurements against manual measurements and across multiple algorithm users to confirm its accuracy and reproducibility. This novel, customizable tool enables efficient and high-fidelity 3D motoneuron analysis, replacing tedious, qualitative, cell-by-cell manual tuning with automatic threshold adaptation and quantified batch settings. For the first time, we attain reproducible results with quantifiable accuracy, exhaustive sampling, and a high degree of objectivity.
- Open Access
- 1 October 2024
- Published by Springer Nature in BMC Biomedical Engineering
- Vol. 6 (1) , 1-10
The neurophysiology of sensorimotor prosthetic control
Movement is a central behavior of daily living; thus lost or compromised movement due to disease, injury, or amputation causes enormous loss of productivity and quality of life. While prosthetics have evolved enormously over the years, restoring natural sensorimotor (SM) control via a prosthesis is a difficult problem which neuroengineering has yet to solve. With a focus on upper limb prosthetics, this perspective article discusses the neurophysiology of motor control under healthy conditions and after amputation, the development of upper limb prostheses from early generations to current state-of-the art sensorimotor neuroprostheses, and how postinjury changes could complicate prosthetic control. Current challenges and future development of smart sensorimotor neuroprostheses are also discussed.
- 1 October 2024
- Published by Springer Nature in BMC Biomedical Engineering
- Vol. 6 (1) , 1-10
Open AccessThe neurophysiology of sensorimotor prosthetic control
Movement is a central behavior of daily living; thus lost or compromised movement due to disease, injury, or amputation causes enormous loss of productivity and quality of life. While prosthetics have evolved enormously over the years, restoring natural sensorimotor (SM) control via a prosthesis is a difficult problem which neuroengineering has yet to solve. With a focus on upper limb prosthetics, this perspective article discusses the neurophysiology of motor control under healthy conditions and after amputation, the development of upper limb prostheses from early generations to current state-of-the art sensorimotor neuroprostheses, and how postinjury changes could complicate prosthetic control. Current challenges and future development of smart sensorimotor neuroprostheses are also discussed.
- Open Access
- 12 July 2024
- Published by MDPI AG in Bioengineering
- Vol. 11 (7) , 707
Adaptive Filtering with Fitted Noise Estimate (AFFiNE): Blink Artifact Correction in Simulated and Real P300 Data
(1) Background: The electroencephalogram (EEG) is frequently corrupted by ocular artifacts such as saccades and blinks. Methods for correcting these artifacts include independent component analysis (ICA) and recursive-least-squares (RLS) adaptive filtering (-AF). Here, we introduce a new method, AFFiNE, that applies Bayesian adaptive regression spline (BARS) fitting to the adaptive filter’s reference noise input to address the known limitations of both ICA and RLS-AF, and then compare the performance of all three methods. (2) Methods: Artifact-corrected P300 morphologies, topographies, and measurements were compared between the three methods, and to known truth conditions, where possible, using real and simulated blink-corrupted event-related potential (ERP) datasets. (3) Results: In both simulated and real datasets, AFFiNE was successful at removing the blink artifact while preserving the underlying P300 signal in all situations where RLS-AF failed. Compared to ICA, AFFiNE resulted in either a practically or an observably comparable error. (4) Conclusions: AFFiNE is an ocular artifact correction technique that is implementable in online analyses; it can adapt to being non-stationarity and is independent of channel density and recording duration. AFFiNE can be utilized for the removal of blink artifacts in situations where ICA may not be practically or theoretically useful.
- 12 July 2024
- Published by MDPI AG in Bioengineering
- Vol. 11 (7) , 707
Open AccessAdaptive Filtering with Fitted Noise Estimate (AFFiNE): Blink Artifact Correction in Simulated and Real P300 Data
(1) Background: The electroencephalogram (EEG) is frequently corrupted by ocular artifacts such as saccades and blinks. Methods for correcting these artifacts include independent component analysis (ICA) and recursive-least-squares (RLS) adaptive filtering (-AF). Here, we introduce a new method, AFFiNE, that applies Bayesian adaptive regression spline (BARS) fitting to the adaptive filter’s reference noise input to address the known limitations of both ICA and RLS-AF, and then compare the performance of all three methods. (2) Methods: Artifact-corrected P300 morphologies, topographies, and measurements were compared between the three methods, and to known truth conditions, where possible, using real and simulated blink-corrupted event-related potential (ERP) datasets. (3) Results: In both simulated and real datasets, AFFiNE was successful at removing the blink artifact while preserving the underlying P300 signal in all situations where RLS-AF failed. Compared to ICA, AFFiNE resulted in either a practically or an observably comparable error. (4) Conclusions: AFFiNE is an ocular artifact correction technique that is implementable in online analyses; it can adapt to being non-stationarity and is independent of channel density and recording duration. AFFiNE can be utilized for the removal of blink artifacts in situations where ICA may not be practically or theoretically useful.
- 1 July 2024
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 132 (1) , 240-258
Onion skin is not a universal firing pattern for spinal motoneurons: simulation study
The literature reports two contrasting schemes, namely the onion skin and the afterhyperpolarization (AHP) regarding the relationship between motor units (MUs) firing rates and recruitment order. Previous studies have examined these schemes phenomenologically, imposing one scheme on the firing-recruitment relationship. Here, we used a high-fidelity computational model that prioritizes biological fidelity and heterogeneity to investigate motoneuron firing schemes without bias toward either scheme. Our objective findings offer an explanation for the longstanding dichotomy on MU firing patterns.
- 1 July 2024
- Published by American Physiological Society in Journal of Neurophysiology
- Vol. 132 (1) , 240-258
Onion skin is not a universal firing pattern for spinal motoneurons: simulation study
The literature reports two contrasting schemes, namely the onion skin and the afterhyperpolarization (AHP) regarding the relationship between motor units (MUs) firing rates and recruitment order. Previous studies have examined these schemes phenomenologically, imposing one scheme on the firing-recruitment relationship. Here, we used a high-fidelity computational model that prioritizes biological fidelity and heterogeneity to investigate motoneuron firing schemes without bias toward either scheme. Our objective findings offer an explanation for the longstanding dichotomy on MU firing patterns.